163 related articles for article (PubMed ID: 366475)
1. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
Isbister WH
N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the mechanism of the leukocyte adherence inhibition test.
Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
5. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
Light PA; Preece AW; Waldron HA
Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a leucocyte adherence test with the leucocyte migration inhibition test and skin reactivity to PPD.
Bullen AW; Losowsky MS
Clin Exp Immunol; 1978 Mar; 31(3):408-13. PubMed ID: 350459
[TBL] [Abstract][Full Text] [Related]
7. Hemocytometer leukocyte adherence inhibition technique.
Maluish AE; Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
[TBL] [Abstract][Full Text] [Related]
8. Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance.
Leveson SH; Howell JH; Paolini NS; Tan MH; Holyoke ED; Goldrosen MH
Cancer Res; 1979 Feb; 39(2 Pt 2):582-6. PubMed ID: 367584
[TBL] [Abstract][Full Text] [Related]
9. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
[TBL] [Abstract][Full Text] [Related]
10. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
11. Further study of specific immunoreactivity in patients with malignant melanoma of uveal tissue by LAI assay.
Kalafut F; Cernák A
Neoplasma; 1982; 29(5):561-6. PubMed ID: 7177245
[TBL] [Abstract][Full Text] [Related]
12. Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer.
Shani A; Fink A; Bass D; Gottesfeld F; Becker S; Levy E; Bentwich Z; Rozen P; Fireman Z; Hallak A
Cancer Detect Prev; 1986; 9(5-6):485-90. PubMed ID: 3779710
[TBL] [Abstract][Full Text] [Related]
13. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
14. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
Goldrosen MH; Howell JH; Holyoke ED
Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
De Carli HO; Restbergs V
Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
[TBL] [Abstract][Full Text] [Related]
18. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
Cochran AJ; Spilg WG; Mackie RM; Thomas CE
Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
[TBL] [Abstract][Full Text] [Related]
19. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
20. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
Raina S; Russo AJ; Jenkins D; Goldrosen MH
Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]